Since gluconeogenesis biochemically opposes glucose catabolism, we hypothesized that glucagon signaling would have a tumor suppressive effect in liver cancer cells that are responsive to glucagon, especially if they express sufficient levels of GCGR and key gluconeogenic enzymes. Here, GCGR is linked to neoplasm.